A detailed history of Cetera Investment Advisers transactions in Immunome Inc. stock. As of the latest transaction made, Cetera Investment Advisers holds 13,529 shares of IMNM stock, worth $148,819. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,529
Previous 68,002 80.1%
Holding current value
$148,819
Previous $822,000 76.03%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$11.7 - $16.51 $637,334 - $899,349
-54,473 Reduced 80.1%
13,529 $197,000
Q2 2024

Aug 22, 2024

SELL
$11.54 - $22.11 $635,807 - $1.22 Million
-55,096 Reduced 44.76%
68,002 $822,000
Q1 2024

May 24, 2024

BUY
$11.01 - $27.34 $1.36 Million - $3.37 Million
123,098 New
123,098 $3.04 Million

Others Institutions Holding IMNM

About Immunome Inc.


  • Ticker IMNM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,127,400
  • Market Cap $133M
  • Description
  • Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...
More about IMNM
Track This Portfolio

Track Cetera Investment Advisers Portfolio

Follow Cetera Investment Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Investment Advisers with notifications on news.